Department of Diabetes and Metabolic Diseases Research

Beckman Research Institute of the City of Hope

National Medical Center

Email: [email protected]

1982  B.Sc., Zoology, Botany, Chemistry, Agra University, India

Publications (selected)

1. Garg P, Krishna M, Singhal S S. Small but mighty: Peptides as next-generation immunotargeting agents in gynecological cancers[J]. Translational Oncology, 2026, 67: 102751.

2. Garg P, Singhal G, Singhal S S. Next-generation viral detection through AI-enhanced nanotechnology: advances, challenges, and future directions[J]. Frontiers in Molecular Biosciences, 2026, 13: 1750124.
3. Garg P, Salgia R, Singhal S S. mRNA-based cancer vaccines: A new frontier in personalized immunotherapy[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2026: 189577.
4. Garg P, Krishna M, Horne D, et al. Hyperthermia-induced apoptosis: The role of magnetic nanoparticles in targeted delivery for breast cancer treatment[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2025: 189490.
5. Garg P, Krishna M, Kulkarni P, et al. Machine learning models for predicting gynecological cancers: advances, challenges, and future directions[J]. Cancers, 2025, 17(17): 2799.
6. Singhal G, Garg P, Mohanty A, et al. Advancing prostate cancer treatment: Innovations and challenges in immunotherapy[J]. Immunotherapies in Solid Tumors: A Team Medicine Approach, 2025: 267-291.
7. Garg P, Pareek S, Kulkarni P, et al. Exploring the potential of TGFβ as a diagnostic marker and therapeutic target against cancer[J]. Biochemical Pharmacology, 2025, 231: 116646.
8. Garg P, Singhal G, Kulkarni P, et al. Artificial intelligence–driven computational approaches in the development of anticancer drugs[J]. Cancers, 2024, 16(22): 3884.
9. Garg P, Pareek S, Kulkarni P, et al. Next-generation immunotherapy: advancing clinical applications in cancer treatment[J]. Journal of clinical medicine, 2024, 13(21): 6537.
10. Kulkarni P, Mohanty A, Ramisetty S, et al. A nexus between genetic and non-genetic mechanisms guides KRAS inhibitor resistance in lung cancer[J]. Biomolecules, 2023, 13(11): 1587.
11. Garg P, Awasthi S, Horne D, et al. The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2023, 1878(4): 188929.
12. Kulkarni P, Mohanty A, Bhattacharya S, et al. Addressing drug resistance in cancer: a team medicine approach[J]. Journal of Clinical Medicine, 2022, 11(19): 5701.
13. Singhal S S, Garg R, Horne D, et al. RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2022, 1877(5): 188803.
14. Singhal S S, Srivastava S, Mirzapoiazova T, et al. Targeting the mercapturic acid pathway for the treatment of melanoma[J]. Cancer Letters, 2021, 518: 10-22.
15. Singh S P, Lee J, Bose C, et al. Haploinsufficiency interactions between RALBP1 and p53 in ERBB2 and PyVT models of mouse mammary carcinogenesis[J]. Cancers, 2021, 13(13): 3329.

Personal Details

https://www.cityofhope.org/research/find-a-scientist/sharad-singhal

https://sciprofiles.com/profile/847497

https://www.hilarispublisher.com/editor/sharad-singhal-5394

WoS Researcher ID: DSO-6054-2022